A new report by TransUnion found that as credit conditions improve for wealthier consumers, others are struggling in the face of higher costs and rising debt burdens. Since 2023, the economy has ...
Pfizer inking the last of three settlements to postpone copycats to its transthyretin amyloid cardiomyopathy (ATTR-CM) med Vyndamax was expected to signal good news for BridgeBio and its rival therapy ...
Georgia’s pre-K program was recently lauded as being one of the best and most far-reaching in the nation. One thing it’s missing: 3-year-olds. The state-funded preschool program has been around for 34 ...
Georgia's Pre-K program met all 10 national quality standards. It is the first and largest universal program to hit every benchmark. State leaders say new funding led to smaller classes and teacher ...
NRx has received a positive review letter (Discipline Review Letter) addressing Drug Quality requesting only “Minor” administrative changes NRx conducted a meeting with leadership of the FDA Office of ...
NEW YORK CITY (PIX11) — New York City is taking another step toward the mayor’s pledge to make child care more accessible, with a major shift coming to its 2‑K program that could ease costs for ...
NEW YORK (WABC) -- Mayor Zohran Mamdani announced on Thursday morning that the city's 2-K program will expand to run for a full day and it will be year-round. Free child care for 2-year-olds begins ...
The FDA has approved the first generic versions of Farxiga, a drug used to treat Type 2 diabetes and reduce the risk of hospitalization for heart failure. The generic, dapagliflozin, is indicated to ...
The FDA approved the first generics of dapagliflozin (Farxiga) tablets for adults with type 2 diabetes, the agency announced on Tuesday. Generics of the SGLT2 inhibitor are indicated for glycemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results